About: http://data.cimple.eu/news-article/7364388a0e708252f16b3b9d39439834d6fee9dd835b4c0a421e88de

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/7364388a0e708252f16b3b9d39439834d6fee9dd835b4c0a421e88de Goto Sponge Distinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Swiss pharmaceuticals giant Roche said Thursday it is collaborating with Atea Pharmaceuticals on the development of an orally administered drug to treat coronavirus patients who have not been hospitalised. "Roche and Atea Pharmaceuticals are joining forces in the fight against Covid-19 to develop, manufacture and distribute AT-527, Atea's investigational oral direct-acting antiviral, to people around the globe," the two companies said in a joint statement. AT-527 is currently being tested in phase 2 clinical trials for use as a treatment for people hospitalised with moderate cases of coronavirus. And phase 3 trials -- the last stage before an application can be made for a new drug to be approved and sold on the market -- are to be held in the first quarter of 2021 where it will be tested on patients outside a hospital setting, Roche said. "AT-527, while being a potential oral treatment option for hospitalised patients, also holds the potential to be the first oral treatment option for Covid-19 patients that are not hospitalised," the statement said. "If successful, AT-527 could help treat patients early, reduce the progression of the infection, and contribute to decreasing the overall burden on health systems." Under the terms of the agreement, the drug, if approved by the relevant authorities, will be distributed in the US by Atea and in the rest of the world by Roche. Financial details of the deal were not disclosed. noo/spm/lc
schema:headline	Roche teams up with Atea in US on oral coronavirus treatment
schema:mentions	Hoffmann-La Roche Antiviral drug Switzerland Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Atea
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-10-22 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	83 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software